Elham Hedayati

742 total citations
44 papers, 438 citations indexed

About

Elham Hedayati is a scholar working on Oncology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Elham Hedayati has authored 44 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 12 papers in Cardiology and Cardiovascular Medicine and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Elham Hedayati's work include Chemotherapy-induced cardiotoxicity and mitigation (11 papers), Cancer Treatment and Pharmacology (8 papers) and Breast Cancer Treatment Studies (8 papers). Elham Hedayati is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (11 papers), Cancer Treatment and Pharmacology (8 papers) and Breast Cancer Treatment Studies (8 papers). Elham Hedayati collaborates with scholars based in Sweden, Germany and Austria. Elham Hedayati's co-authors include Maria Albertsson, Håkan Nyman, Maryam Hazrati, Hassan Alinaghizadeh, Marzieh Momennasab, Sareh Keshavarzi, Jonas Bergh, Anna Marklund, Frida E. Lundberg and Kenny A. Rodriguez‐Wallberg and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Elham Hedayati

39 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elham Hedayati Sweden 12 165 111 79 50 49 44 438
Jacqueline B. Vo United States 13 169 1.0× 74 0.7× 48 0.6× 98 2.0× 29 0.6× 51 404
Rhodé M. Bijlsma Netherlands 13 197 1.2× 60 0.5× 115 1.5× 39 0.8× 35 0.7× 43 494
Rhea Harewood United Kingdom 10 339 2.1× 128 1.2× 63 0.8× 11 0.2× 43 0.9× 13 517
Nicole P. M. Ezendam Netherlands 18 542 3.3× 115 1.0× 130 1.6× 13 0.3× 48 1.0× 43 826
Rebeca Franco United States 14 243 1.5× 69 0.6× 102 1.3× 12 0.2× 33 0.7× 39 580
Suzanne E. J. Kaal Netherlands 15 307 1.9× 193 1.7× 246 3.1× 59 1.2× 90 1.8× 48 851
Gretchen Keel United States 10 455 2.8× 158 1.4× 255 3.2× 104 2.1× 66 1.3× 10 991
Ridgely Fisk Green United States 14 76 0.5× 51 0.5× 161 2.0× 20 0.4× 99 2.0× 23 865
Benjamin Barnes Germany 13 257 1.6× 63 0.6× 121 1.5× 8 0.2× 52 1.1× 29 530
Heidy N. Medina United States 13 173 1.0× 50 0.5× 63 0.8× 14 0.3× 24 0.5× 30 388

Countries citing papers authored by Elham Hedayati

Since Specialization
Citations

This map shows the geographic impact of Elham Hedayati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elham Hedayati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elham Hedayati more than expected).

Fields of papers citing papers by Elham Hedayati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elham Hedayati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elham Hedayati. The network helps show where Elham Hedayati may publish in the future.

Co-authorship network of co-authors of Elham Hedayati

This figure shows the co-authorship network connecting the top 25 collaborators of Elham Hedayati. A scholar is included among the top collaborators of Elham Hedayati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elham Hedayati. Elham Hedayati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hedayati, Elham, et al.. (2025). Capillary Blood Self‐Sampling for Therapeutic Drug Monitoring: A Mixed‐Methods Usability Study of the True Dose ® Kit. BioMed Research International. 2025(1). 9973081–9973081.
2.
Karsten, Maria Margarete, Linetta B. Koppert, Jonas Bergh, et al.. (2025). Benchmarking cancer outcomes in Europe: a scoping review of methodologies and case-mix adjustments. PubMed. 9. 100176–100176.
3.
Blohmer, Jens‐Uwe, et al.. (2024). Subtype-Specific Survival of Young Women with Breast Cancer and Its Interaction with the Germline BRCA Status. Cancers. 16(4). 738–738. 1 indexed citations
4.
Stenmarker, Margaretha, Elham Hedayati, Kenny A. Rodriguez‐Wallberg, et al.. (2024). Morbidity and mortality among children, adolescents, and young adults with cancer over six decades: a Swedish population-based cohort study (the Rebuc study). The Lancet Regional Health - Europe. 42. 100925–100925. 3 indexed citations
5.
Ligt, Kelly M. de, Belle H. de Rooij, Elham Hedayati, et al.. (2023). International development of a patient-centered core outcome set for assessing health-related quality of life in metastatic breast cancer patients. Breast Cancer Research and Treatment. 198(2). 265–281. 10 indexed citations
6.
Hägglund, H, Martin Jönsson, Elham Hedayati, Christel Hedman, & Therese Djärv. (2023). Poorer survival after out-of-hospital cardiac arrest among cancer patients: a population-based register study. European Heart Journal Acute Cardiovascular Care. 12(8). 495–503.
7.
8.
Ligt, Kelly M. de, Belle H. de Rooij, Elham Hedayati, et al.. (2022). International development of a patient-centered core outcome set for assessing health-related quality of life in metastatic breast cancer patients. Zenodo (CERN European Organization for Nuclear Research). 2 indexed citations
9.
Ntekim, Atara, et al.. (2022). How COVID-19 changed clinical research strategies: a global survey. Journal of International Medical Research. 50(4). 3629154107–3629154107. 8 indexed citations
10.
Altena, Renske, Sofie A. M. Gernaat, Ulla Wilking, et al.. (2022). Use of sickness benefits by patients with metastatic breast cancer—A Swedish cohort study. European Journal of Cancer Care. 31(5). e13626–e13626. 2 indexed citations
11.
12.
Altena, Renske, Laila Hűbbert, Narsis A. Kiani, et al.. (2021). Evidence-based prediction and prevention of cardiovascular morbidity in adults treated for cancer. Cardio-Oncology. 7(1). 20–20. 9 indexed citations
13.
Gernaat, Sofie A. M., Aina Johnsson, Renske Altena, Ulla Wilking, & Elham Hedayati. (2020). Sickness absence and disability pension among swedish women prior to breast cancer relapse with a special focus on the roles of treatment and comorbidity. European Journal of Cancer Care. 30(1). e13353–e13353. 5 indexed citations
14.
Hedayati, Elham, Andri Papakonstantinou, Agneta Månsson‐Broberg, et al.. (2020). Approaches to management of cardiovascular morbidity in adult cancer patients – cross-sectional survey among cardio-oncology experts. Cardio-Oncology. 6(1). 16–16. 2 indexed citations
15.
Garvin, Stina, et al.. (2019). Differences in intra-tumoral macrophage infiltration and radiotherapy response among intrinsic subtypes in pT1-T2 breast cancers treated with breast-conserving surgery. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 475(2). 151–162. 12 indexed citations
16.
Brand, Judith S., Elham Hedayati, Keith Humphreys, et al.. (2016). Chemotherapy, Genetic Susceptibility, and Risk of Venous Thromboembolism in Breast Cancer Patients. Clinical Cancer Research. 22(21). 5249–5255. 11 indexed citations
17.
Foukakis, Theodoros, John Lövrot, Linda S. Lindström, et al.. (2015). Gene expression profiling of sequential metastatic biopsies for biomarker discovery in breast cancer. Molecular Oncology. 9(7). 1384–1391. 11 indexed citations
18.
Hedayati, Elham, et al.. (2012). Cognitive, psychosocial, somatic and treatment factors predicting return to work after breast cancer treatment. Scandinavian Journal of Caring Sciences. 27(2). 380–387. 26 indexed citations
19.
Hedayati, Elham, et al.. (2011). The effects of breast cancer diagnosis and surgery on cognitive functions. Acta Oncologica. 50(7). 1027–1036. 19 indexed citations
20.
Hedayati, Elham, et al.. (2011). Effects of adjuvant treatment on cognitive function in women with early breast cancer. European Journal of Oncology Nursing. 16(3). 315–322. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacqueline B. Vo Breakdown of academic impact, for papers by Rhodé M. Bijlsma Breakdown of academic impact, for papers by Rhea Harewood Breakdown of academic impact, for papers by Nicole P. M. Ezendam Breakdown of academic impact, for papers by Rebeca Franco Breakdown of academic impact, for papers by Suzanne E. J. Kaal Breakdown of academic impact, for papers by Gretchen Keel Breakdown of academic impact, for papers by Ridgely Fisk Green Breakdown of academic impact, for papers by Benjamin Barnes Breakdown of academic impact, for papers by Heidy N. Medina
Rankless by CCL
2026